Combo DAA May Benefit Patients With Resistant HCV Genotype 3 Combo DAA May Benefit Patients With Resistant HCV Genotype 3

A meta-analysis of 34 research reports found that direct-acting antiviral (DAA) combo treatment can be effective in achieving sustained virologic response in patients with HCV genotype 3.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news